What is ZMapp Drug?

In August, 2014, Mapp Biopharmaceutical offered the drug ZMapp to two US doctors who got affected with the Ebola disease. The drug uses a novel method of passive immunization to treat Ebola disease by inserting genetically altered Ebola protein into tobacco leaves. However, it has been tested only on monkeys so far and it was to be tested on human volunteers in 2015. The abrupt outbreak of Ebola hastened the development. World Health Organisation (WHO) has approved the use of drug ZMapp now to combat Ebola spread as the death count surged.